Evidence map›Paper›PMID 42083048›Full record

SynthesisHuman genomics2026

Genotype-phenotype correlations and mutation spectrum of GBA1 in Gaucher disease across Asian populations: a systematic review.

Amina Konarbayeva, Sabina Atavliyeva, Dana Auganova, Salima Baduanova, Pavel Tarlykov

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Human genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amina KonarbayevaNational Center for Biotechnology, Astana, Kazakhstan.
Sabina AtavliyevaNational Center for Biotechnology, Astana, Kazakhstan. atavliyeva@biocenter.kz.
Dana AuganovaNational Center for Biotechnology, Astana, Kazakhstan.
Salima BaduanovaNational Center for Biotechnology, Astana, Kazakhstan.
Pavel TarlykovNational Center for Biotechnology, Astana, Kazakhstan.

Funding

The Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan BR24992881
6 · The paper itself

Abstract

backgroundGaucher disease exhibits substantial genetic heterogeneity across populations. Asian populations remain understudied despite representing diverse genetic backgrounds. The systematic review was conducted to identify GBA1 mutations and genotype-phenotype correlations in Asian populations.

methodsFollowing PRISMA guidelines, three databases were searched (January 2000 to December 2025) for studies reporting GBA1 mutations in Asian populations (World Bank classification). From 58 included studies, 419 patients were analyzed with complete genotype-phenotype data. Meta-analyses with Freeman-Tukey transformation estimated pooled proportions of GBA1 variants among reported Gaucher disease cases. Genotype-phenotype associations were assessed using Fisher's exact or chi-square tests. Logistic regression identified predictors of severe phenotype.

results162 distinct genotypes across 15 countries were identified, with 94% represented by ≤ 4 patients. The GBA1 variant L444P was the most prevalent (pooled proportion: 0.46), contrasting with Ashkenazi populations where the N370S variant predominates. N370S clustered in West Asia (Iraq 58%, Turkey 30%) but was present at very low frequencies or absent in East Asian countries.

conclusionGaucher disease in the Asian population exhibits distinct mutation spectra and geographic patterns requiring population-specific diagnostic strategies. Due to high genetic heterogeneity, broad sequencing approaches are more appropriate than limited targeted panels.

Indexed as

Asian PeopleGaucher DiseaseGenetic Association StudiesGlucosylceramidaseMutationAsiaGenotypeHumansPhenotypeGBA protein, humanGlucosylceramidaseAsiaEpidemiologyGaucher diseaseGBA1 geneGenetic variationGenotype–phenotype correlationLysosomal storage disorders

Identifiers

PMID42083048
PMCPMC13288584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.